🇺🇸 FDA
Pipeline program

sterile saline solution (0.9% w/v solution of NaCl in water).

219685

Phase 2 small_molecule active

Quick answer

sterile saline solution (0.9% w/v solution of NaCl in water). for Urinary Tract Infections is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline Biologicals S.A.
Indication
Urinary Tract Infections
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials